These final results, together with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two aid the principle of targeting ACKR3 as a singular method to modulate the opioid program, which could open up new therapeutic avenues for opioid-relevant Ailments.Importantly, these receptors w